Cases exceeding the 90th percentile for dose, though infrequent, resulted in greater cumulative exposures for all cath lab staff.

Intracoronary delivery of an injectable bioabsorbable alginate, known as the bioabsorbable cardiac matrix (BCM), does not decrease adverse left ventricular (LV) remodelling or cardiac events at 6 ...

Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.

McKenzie Health System earned two American Heart Association awards, credited with improving cardiac and stroke care in rural ...

A new study published in the journal of PloS One showed that although reoperative therapy with evolocumab with rosuvastatin ...

A new study finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital. If you suffer a heart attack ...

Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.

It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...

A STEMI is generally defined as an Electrocardiogram (EKG) with ST elevation of greater than 1 mm in 2 or more contiguous leads. It has also been defined as a "new" Left Bundle Branch Block (LBBB) in ...